Tenor Capital Management »

Pacira Biosciences shares owned by Tenor Capital Management

Quarter-by-quarter ownership of Pacira Biosciences shares owned by Tenor Capital Management from 13F filings

Historical chart of Tenor Capital Management investment in Pacira Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Pacira Biosciences held by Tenor Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pacira Biosciences by Tenor Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.3B 6.8M 926.96

More positions owned by Tenor Capital Management

Palo Alto Networks Note 0.375% 6/0 (Principal)
Insight Enterprises Note 0.750% 2/1 (Principal)
Ziff Davis Note 1.750%11/0 (Principal)
Insulet Corp Note 0.375% 9/0 (Principal)
Block Note 0.125% 3/0 (Principal)
Zscaler Note 0.125% 7/0 (Principal)
Tandem Diabetes Care Note 1.500% 5/0 (Principal)
Alteryx Note 0.500% 8/0 (Principal)
Five9 Note 0.500% 6/0 (Principal)
Mongodb Note 0.250% 1/1 (Principal)
Liberty Media Corp Note 2.750% 12/0 (Principal)
United States Stl Corp Note 5.000%11/0 (Principal)
Ati Note 3.500% 6/1 (Principal)
Evolent Health Note 1.500%10/1 (Principal)
Hubspot Note 0.375% 6/0 (Principal)

View all positions for Tenor Capital Management

Top funds holding Pacira Biosciences

Wellesley Investment Advisors
Capstone Investment Advisors
Lazard Asset Management
MacKay Shields
Steelhead Partners
Calamos Advisors
III Capital Management
M&g Investment Management
Fort Baker Capital Management
Aequim Alternative Investments
Tenor Capital Management
Palisade Capital Management
Jpmorgan Chase & Co
Credit Suisse
Barclays

View all funds holding Pacira Biosciences